Latest News and Press Releases
Want to stay updated on the latest news?
-
BGB Group appoints Julie Yoon Chief Client Officer to strengthen client engagement & deliver breakthrough thinking across the commercialization lifecycle.
-
Exousia Pro, OTCPK: MAJI, announces the commencement of the first critical phase in bringing its revolutionary cancer screening test to the global market.
-
PONTE VEDRA, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and...
-
BEIJING, March 25, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the annual...
-
เมืองออกซ์ฟอร์ด สหราชอาณาจักร, March 18, 2026 (GLOBE NEWSWIRE) -- Refeyn ผู้พัฒนาเทคโนโลยีแมสโฟโตเมตรีระดับบุกเบิก ประกาศเปิดตัวเครื่องแมสโฟโตมิเตอร์ MyMass™ (MyMassMP)...
-
OXFORD, Reino Unido, March 18, 2026 (GLOBE NEWSWIRE) -- Refeyn, desarrollador de la tecnología pionera de la fotometría de masa, anuncia el lanzamiento del fotómetro de masa MyMass™ (MyMassMP), un...
-
OXFORD, Reino Unido, March 18, 2026 (GLOBE NEWSWIRE) -- A Refeyn, desenvolvedora da pioneira tecnologia de fotometria de massa, anuncia o lançamento do fotômetro de massa MyMass™ (MyMassMP), um...
-
אוקספורד, בריטניה, March 18, 2026 (GLOBE NEWSWIRE) -- Refeyn, מפתחת טכנולוגיית פוטומטריית מסה פורצת דרך, מכריזה על השקת פוטומטריית המסה MyMass™ (MyMassMP), מכשיר קומפקטי שנועד לספק מענה לשאלת מחקר...
-
OXFORD, Royaume-Uni, 18 mars 2026 (GLOBE NEWSWIRE) -- Refeyn, acteur pionnier du développement de technologies de photométrie de masse, annonce le lancement de MyMass™ (MyMassMP), un photomètre de...
-
Refeyn launches MyMass™ — an all-in-one mass photometer for fast, accurate sample quality assessment ahead of costly structural biology workflows.